Protagenic Therapeutics, Incnew S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OQB
Protagenic Therapeutics is registering the resale of 5,844,885 shares of common stock by selling stockholders, including shares issued in a recent private placement and those issuable upon exercise of warrants.